Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2002 Sep;52(482):729–734.

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

T C M Christiaens 1, M De Meyere 1, G Verschraegen 1, W Peersman 1, S Heytens 1, J M De Maeseneer 1
PMCID: PMC1314413  PMID: 12236276

Abstract

BACKGROUND: Urinary tract infections (UTIs) are very common and have been treated with apparent success with antimicrobials for many years. However, there is a paucity of placebo-controlled clinical trials. AIM: To measure the symptomatic and bacteriological short-term effect of nitrofurantoin treatment versus placebo, in the treatment of uncomplicated UTI in adult non-pregnant women. DESIGN OF STUDY: Randomised placebo-controlled trial in general practice. SETTING: Non-pregnant women, aged between 15 and 54 years old, consulting a general practitioner for symtoms suggestive of uncomplicated lower UTI and with pyuria (positive for leucocyte esterase test). METHOD: A dipslide was inoculated in first-void midstream urine and sent for examinion. The patients were randomised to receive nitrofurantoin 100 mg or placebo four times daily for three days. After three, seven, and 14 days a new dipslide was inoculated and symptoms of UTI were checked or improvement of symptoms and bacteriuria. RESULTS: Of 166 women consulting with symptoms suggestive for UTI, 78 had pyuia and agreed to participate in the study (the clinically suspected UTI group); of these, 40 received nitrofurantoin and 38 received placebo. The result for combined symptomatic improvement and cure after three days was 27/35 in the nitrofurantoin group and 19/35 in the placebo group (c2 with Yates' correction P = 0.008; number needed to treat [NNT] = 4.4, 95% confidence interval [CI] = 2.3 to 79). After seven days, combined improvement and cure was observed in 30/34 and 17/33 respectively (P = 0.003, NNT = 2.7, 95% CI = 1.8 to 6.0). At inclusion, 56 women had bacteriuria of > or = 10(5) CFU/ml (the bacteriologically proven UTI group). Of these, 29 received nitrofurantoin and 27 received placebo. After three days the bacteriological cure was 21/26 in the treatment group, compared with 5/25 in the placebo group (P < 0.001; NNT = 1.6, 95% CI= 1.2 to 2.6). After seven days the bacteriological cure rate was 17/23 in the intervention group and 9/22 in the placebo group (P = 0.05, NNT = 3, 95% CI = 1.7 to 17). CONCLUSION: In women with bacteriologically proven UTI, nitrofurantoin was significantly more effective than placebo in achieving bacteriological cure and symptomatic relief in just three days; this was still present after seven days. In patients with clinically suspected UTI the symptomatic effect was statistically significant after

Full Text

The Full Text of this article is available as a PDF (82.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. G. Confidence intervals for the number needed to treat. BMJ. 1998 Nov 7;317(7168):1309–1312. doi: 10.1136/bmj.317.7168.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asbach H. W. Single dose oral administration of cefixime 400mg in the treatment of acute uncomplicated cystitis and gonorrhoea. Drugs. 1991;42 (Suppl 4):10–13. doi: 10.2165/00003495-199100424-00005. [DOI] [PubMed] [Google Scholar]
  3. Brooks D., Garrett G., Hollihead R. Sulphadimidine, co-trimoxazole, and a placebo in the management of symptomatic urinary tract infection in general practice. J R Coll Gen Pract. 1972 Oct;22(123):695–703. [PMC free article] [PubMed] [Google Scholar]
  4. Brooks D. The management of suspected urinary tract infection in general practice. Br J Gen Pract. 1990 Oct;40(339):399–401. [PMC free article] [PubMed] [Google Scholar]
  5. Christiaens T. H., Heytens S., Verschraegen G., De Meyere M., De Maeseneer J. Which bacteria are found in Belgian women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95-96? Acta Clin Belg. 1998 Jun;53(3):184–188. [PubMed] [Google Scholar]
  6. Dubi J., Chappuis P., Darioli R. Traitement de l'infection urinaire par une dose unique de co-trimoxazole comparée à une dose unique d'amoxycilline et à un placebo. Schweiz Med Wochenschr. 1982 Jan 16;112(3):90–92. [PubMed] [Google Scholar]
  7. Echols R. M., Tosiello R. L., Haverstock D. C., Tice A. D. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis. 1999 Jul;29(1):113–119. doi: 10.1086/520138. [DOI] [PubMed] [Google Scholar]
  8. Feinstein A. R., Concato J. The quest for "power": contradictory hypotheses and inflated sample sizes. J Clin Epidemiol. 1998 Jul;51(7):537–545. doi: 10.1016/s0895-4356(98)00029-8. [DOI] [PubMed] [Google Scholar]
  9. Hooton T. M., Stam W. E. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am. 1991 Mar;75(2):339–357. doi: 10.1016/s0025-7125(16)30458-8. [DOI] [PubMed] [Google Scholar]
  10. Hooton T. M., Winter C., Tiu F., Stamm W. E. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 1995 Jan 4;273(1):41–45. [PubMed] [Google Scholar]
  11. Knottnerus J. A., Bouter L. M. The ethics of sample size: two-sided testing and one-sided thinking. J Clin Epidemiol. 2001 Feb;54(2):109–110. doi: 10.1016/s0895-4356(00)00276-6. [DOI] [PubMed] [Google Scholar]
  12. Leibovici L., Wysenbeek A. J. Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a meta-analysis of randomized trials. Q J Med. 1991 Jan;78(285):43–57. [PubMed] [Google Scholar]
  13. Mabeck C. E. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad Med J. 1972 Feb;48(556):69–75. [PMC free article] [PubMed] [Google Scholar]
  14. O'Dowd T. C., Ribeiro C. D., Munro J., West R. R., Howells C. H., Davis R. H. Urethral syndrome: a self limiting illness. Br Med J (Clin Res Ed) 1984 May 5;288(6427):1349–1352. doi: 10.1136/bmj.288.6427.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pappas P. G. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am. 1991 Mar;75(2):313–325. doi: 10.1016/s0025-7125(16)30456-4. [DOI] [PubMed] [Google Scholar]
  16. Patton J. P., Nash D. B., Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am. 1991 Mar;75(2):495–513. doi: 10.1016/s0025-7125(16)30466-7. [DOI] [PubMed] [Google Scholar]
  17. Scheer W. D. The detection of leukocyte esterase activity in urine with a new reagent strip. Am J Clin Pathol. 1987 Jan;87(1):86–93. doi: 10.1093/ajcp/87.1.86. [DOI] [PubMed] [Google Scholar]
  18. Stamm W. E., Counts G. W., Running K. R., Fihn S., Turck M., Holmes K. K. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med. 1982 Aug 19;307(8):463–468. doi: 10.1056/NEJM198208193070802. [DOI] [PubMed] [Google Scholar]
  19. Stamm W. E., Hooton T. M. Management of urinary tract infections in adults. N Engl J Med. 1993 Oct 28;329(18):1328–1334. doi: 10.1056/NEJM199310283291808. [DOI] [PubMed] [Google Scholar]
  20. Stamm W. E., Running K., McKevitt M., Counts G. W., Turck M., Holmes K. K. Treatment of the acute urethral syndrome. N Engl J Med. 1981 Apr 16;304(16):956–958. doi: 10.1056/NEJM198104163041608. [DOI] [PubMed] [Google Scholar]
  21. Trienekens T. A., Stobberingh E. E., Winkens R. A., Houben A. W. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. BMJ. 1989 Nov 25;299(6711):1319–1322. doi: 10.1136/bmj.299.6711.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wilkie M. E., Almond M. K., Marsh F. P. Diagnosis and management of urinary tract infection in adults. BMJ. 1992 Nov 7;305(6862):1137–1141. doi: 10.1136/bmj.305.6862.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES